ERBB2 and breast carcinoma: However, due to cancer therapies such as radiation, chemotherapy, human epidermal growth factor receptor-2 (HER-2) inhibitors and more recently, immunotherapy, more patients have been surviving breast cancer [2, 3].However, cardiovascular disease remains a leading cause of death in breast cancer patients [4, 5].